[68Ga]-Pentixafor PET/CT for CXCR4-Mediated Imaging of Vestibular Schwannomas
We have recently demonstrated CXCR4 overexpression in vestibular schwannomas (VS). This study investigated the feasibility of CXCR4-directed positron emission tomography/computed tomography (PET/CT) imaging of VS using the radiolabeled chemokine ligand [68Ga]Pentixafor.Methods: 4 patients with 6 pri...
Main Authors: | Maria Breun, Camelia M. Monoranu, Almuth F. Kessler, Cordula Matthies, Mario Löhr, Carsten Hagemann, Andreas Schirbel, Steven P. Rowe, Martin G. Pomper, Andreas K. Buck, Hans-Jürgen Wester, Ralf-Ingo Ernestus, Constantin Lapa |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2019-06-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fonc.2019.00503/full |
Similar Items
-
Fully-automated production of [68Ga]Ga-PentixaFor on the module Modular Lab-PharmTracer
by: Sarah Spreckelmeyer, et al.
Published: (2020-02-01) -
CXCR4-Directed Imaging in Solid Tumors
by: Rudolf A. Werner, et al.
Published: (2019-08-01) -
Response assessment with the CXCR4-directed positron emission tomography tracer [68Ga]Pentixafor in a patient with extranodal marginal zone lymphoma of the orbital cavities
by: Peter Herhaus, et al.
Published: (2017-06-01) -
Analysis of ADAM9 regulation and function in vestibular schwannoma primary cells
by: Anja Nattmann, et al.
Published: (2020-11-01) -
Pentixafor PET/CT for imaging of chemokine receptor 4 expression in esophageal cancer – a first clinical approach
by: Philipp Linde, et al.
Published: (2021-02-01)